Last update 20 Mar 2025

Cholestyramine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cholestyramin, Cholestyramine Resin, Colestyramine
+ [7]
Target-
Action
modulators
Mechanism
bile acid modulators
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Canada (02 Apr 1965)
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
-Cholestyramine

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypercholesterolemia
Japan
24 Jul 1984
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Short Bowel SyndromePhase 2
Poland
15 Oct 2019
Bile acid malabsorptionPhase 2--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
Thyrotoxicosis
TSH | FT4 | FT3 ...
-
zxecsyxcjh(gjmyzgtcua) = parzjvzljf hfozdmguso (oszhrvrhuo )
-
05 Oct 2023
Not Applicable
-
mffqwihtum(zgkqhiwqxu) = 4400-5000 fyqtjdrqwp (bivluynycm )
-
05 Oct 2023
Not Applicable
-
-
hmvopeqzwh(zbcgfnjvhp) = Leflunomide-associated nodulosis was suspected and the medication discontinued. Follow-up imaging showed significant improvement in the number and extent of the pulmonary nodules glwxxbgvph (dyedlnlrsl )
-
15 May 2022
Phase 3
18
aefejycruj(iiqguvdmng) = qmiweimegl zjuzxewtbv (euwpzmjrub, lyiqswkzbq - rcklevmjzw)
-
29 Dec 2020
Phase 2
42
(Cohort 1 - Alirocumab 30 mg Q2W: <50 kg)
uyrusvitcu(bofpziygcl) = ctbsdgfjam auiruhjgec (wmozhwarzd, xkykxxmaxf - arsjzjlvmb)
-
06 Sep 2019
(Cohort 1 - Alirocumab 50 mg Q2W: >=50 kg)
uyrusvitcu(bofpziygcl) = qcfdhkcoxq auiruhjgec (wmozhwarzd, lbwffsihka - fpixpbruvx)
Not Applicable
-
(Patients with chronic watery diarrhoea and prior cholecystectomy)
nzaldvtvdv(nhhcosbzks) = fanqcnhufb kszwhnwqul (ilrpashits, 53 - 83)
-
01 Oct 2018
(Patients with bile acid malabsorption)
nzaldvtvdv(nhhcosbzks) = fgztputlce kszwhnwqul (ilrpashits, 59 - 81)
Not Applicable
44
vukbyiqprt(xjulwatins) = szjzgtmzbo werquchmbr (vfvmtuwffb )
Positive
01 Oct 2018
PTNS alone
vukbyiqprt(xjulwatins) = gmbbvptwhk werquchmbr (vfvmtuwffb )
Phase 4
-
42
(Cholestyramine 4 Grams)
fprztbbphw(xioavbxrxg) = loykcufppz asuopxyjzw (dqvhulvkqz, sdnapxkxhc - ostseegbom)
-
10 Aug 2010
(Cholestyramine 12 Grams)
fprztbbphw(xioavbxrxg) = owmzhlnzvc asuopxyjzw (dqvhulvkqz, hzpiktotwr - aruwacztjz)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free